This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Gossamer Bio Completes Debt Exchange
Business debt exchange offer

Gossamer Bio Completes Debt Exchange

Analysis based on 8 articles · First reported Jun 02, 2026 · Last updated Jun 17, 2026

Sentiment
20
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market impact is generally positive for Gossamer Bio as the exchange offer aims to improve its financial structure by replacing existing convertible notes with new ones and equity securities. This could lead to increased investor confidence and potentially a more stable stock price for Gossamer Bio.

Biotechnology Pharmaceuticals
Event Summary

Gossamer Bio announced the final tender results of its exchange offer for its 5.00% Convertible Senior Notes due 2027. The company offered new 7.50% Convertible Senior Secured First Lien Notes due 2030, common stock, and warrants in exchange for the existing notes. The early tender date was extended to June 2, 2026, and the minimum tender condition was amended from 98% to 90.5%. Early settlement occurred on June 4, 2026, and Gossamer Bio entered into a supplemental indenture to eliminate restrictive covenants on the Existing Convertible Notes. Approximately $18.9 million of the Existing Convertible Notes will remain outstanding.

Entities Involved
stock
Gossamer Bio
Gossamer Bio initiated an exchange offer for its Existing Convertible Notes to reduce debt and improve its financial structure, which is expected to have a positive impact on the company's financial health.
Importance 100.0 Sentiment 20.0
priv
D.F. King & Co.
D.F. King & Co. acted as the exchange agent and information agent for Gossamer Bio's exchange offer, facilitating the process.
Importance 20.0 Sentiment 0.0
govactor
United States — United States Securities and Exchange Commission
Gossamer Bio's filings with the United States — United States Securities and Exchange Commission provide transparency and regulatory oversight for its financial activities.
Importance 10.0 Sentiment 0.0
index
Nasdaq-100
Nasdaq-100 is the stock exchange where Gossamer Bio's shares are traded, providing the platform for its public listing.
Importance 10.0 Sentiment 0.0
Relationships
Gossamer Bio related ↔ Nasdaq-100
United States — United States Securities and Exchange Commission related ↔ Nasdaq-100
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.